Lupin, Concord Biotech get USFDA nod for generic immunosuppressant capsules

In alliance with Concord Biotech, the company has received approval from the United States Food and Drug Administration (USFDA) to market Tacrolimus capsules USP, in the strengths of 0.5 mg, 1 mg, and 5 mg, Lupin said in a filing to the BSE.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news